OpGen (OPGN) rockets 30% on covid-19 coronavirus test availability in apparent response to its post on social media that it is offering a 10-minute COVID-19 IgG/IgM test kit that the FDA has approved for emergency use during the pandemic. Shares were up 100% intraday before retracing.
OpGen (OPGN) Market Performance
OPGN stocks went down by -2.21% for the week, with the monthly jump of 2.79% and a quarterly performance of -1.34%, while its annual performance rate touched -66.00%. The simple moving average for the period of the last 20 days is 26.37% for OPGN stocks with the simple moving average of 41.84% for the last 200 days.
Analysts’ Opinion on OpGen, Inc. (OPGN)
Many brokerage firms have already submitted their reports for OPGN stocks, with Alliance Global Partners repeating the rating for OPGN shares by setting it to “Buy”. The predicted price for OPGN socks in the upcoming period according to Alliance Global Partners is $2.30 based on the research report published on March 1, 2019.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see OPGN stock at the price of $9, previously predicting the value of $1. The rating they have provided for OPGN stocks is “Buy” according to the report published on February 7, 2018.
OpGen (OPGN) Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at OpGen, Inc. (OPGN), starting from Curetis N.V. in Liquidation, who sold 19 shares at the price of $2.20 back on May 07. After this action, Rushing now owns 0 shares of OpGen, Inc., valued at $42 with the latest closing price.
Curetis N.V. in Liquidation, the 10% Owner of OpGen, Inc., sold 46,612 shares at the value of $2.17 during a trade that took place back on Apr 23, which means that Curetis N.V. in Liquidation is holding 1,622,568 shares at the value of $101,148 based on the most recent closing price.
OpGen (OPGN) Stock Fundamentals
The current profitability levels are settled at -313.59 for the present operating margin and +53.36 for gross margin. The net margin for OpGen, Inc. stands at -355.75. Total capital return value is set at -173.36, while invested capital returns managed to touch -251.71. Equity return holds the value -269.10%, with -110.10% for asset returns.
Based on OpGen, Inc. (OPGN), the company’s capital structure generated 73.60 points for debt to equity in total, while total debt to capital is set at the value of 42.40. Total debt to assets is settled at the value of 30.32 with long-term debt to equity ratio rests at -58.50 and long-term debt to capital is 27.72.
Is OpGen (OPGN) a reliable investment?
Shares of OpGen (OPGN) appear to be a very good investment option, the Money Midnight Indicator is expecting its price to increase considerably in the next several months. The majority of the metrics point to this investment being highly attractive.
Looking to beat the market?
Sign up and get Money Signals straight to your phone with over 50% in profits! Join now!
